- Home
- BLIN vs EVAX Comparison
BLIN vs EVAX Comparison
Compare BLIN & EVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLIN
- EVAX
- Stock Information
- Founded
- BLIN 2000
- EVAX 2008
- Country
- BLIN United States
- EVAX Denmark
- Employees
- BLIN N/A
- EVAX N/A
- Industry
- BLIN EDP Services
- EVAX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BLIN Technology
- EVAX Health Care
- Exchange
- BLIN Nasdaq
- EVAX Nasdaq
- Market Cap
- BLIN 16.5M
- EVAX 17.8M
- IPO Year
- BLIN 2007
- EVAX 2021
- Fundamental
- Price
- BLIN $1.33
- EVAX $5.76
- Analyst Decision
- BLIN Strong Buy
- EVAX Strong Buy
- Analyst Count
- BLIN 1
- EVAX 3
- Target Price
- BLIN $4.62
- EVAX $12.33
- AVG Volume (30 Days)
- BLIN 112.0K
- EVAX 831.7K
- Earning Date
- BLIN 08-14-2025
- EVAX 11-07-2025
- Dividend Yield
- BLIN N/A
- EVAX N/A
- EPS Growth
- BLIN N/A
- EVAX N/A
- EPS
- BLIN N/A
- EVAX N/A
- Revenue
- BLIN $15,375,000.00
- EVAX $3,176,000.00
- Revenue This Year
- BLIN $2.45
- EVAX $129.34
- Revenue Next Year
- BLIN $16.36
- EVAX N/A
- P/E Ratio
- BLIN N/A
- EVAX N/A
- Revenue Growth
- BLIN 0.54
- EVAX 1042.45
- 52 Week Low
- BLIN $1.04
- EVAX $1.20
- 52 Week High
- BLIN $2.80
- EVAX $14.81
- Technical
- Relative Strength Index (RSI)
- BLIN 48.65
- EVAX 49.63
- Support Level
- BLIN $1.26
- EVAX $5.29
- Resistance Level
- BLIN $1.35
- EVAX $6.82
- Average True Range (ATR)
- BLIN 0.08
- EVAX 1.27
- MACD
- BLIN -0.00
- EVAX -0.29
- Stochastic Oscillator
- BLIN 69.04
- EVAX 6.85
About BLIN Bridgeline Digital Inc.
Bridgeline Digital Inc is a AI-powered marketing technology company that offers a suite of products that help companies grow online revenue by driving more traffic to their websites, converting more visitors to purchasers, and increasing average order value. Company software is available through a cloud-based Software as a Service (SaaS) model. It helps to maximize the performance of critical websites, intranets, and online stores. The company generates revenue from digital engagement services, subscription, perpetual licenses, maintenance, and hosting. Geographically, it derives a majority of revenue from the United States.
About EVAX Evaxion Biotech
Evaxion AS is a techBio company based on its AI platform, AI-Immunology. Evaxion's proprietary and scalable AI prediction models harness the power of artificial intelligence to decode the human immune system and develop novel immunotherapies for cancer, bacterial diseases, and viral infections. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing innovative and targeted treatment options.